Organon makes women's health drugs, biosimilars and established brands sold to wholesalers, hospitals and healthcare providers. It last closed at $13.90 on Nov 17, down 0.04% on the day. OGN reports earnings on Thu, Feb 11, 2027. In the past 30 days there were 1 dark pool print totaling $731K, the largest $731K.
OGN · as of the Nov 17 close · updated after every close
Moving sideways, nearing overbought
The stock is 1% above its 20 day and 1% above its 50 day average. It is 15% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 67), near overbought. The nearest support is the Pivot S1 at $13.89, and the nearest resistance the Pivot R1 at $13.91.
Short trendNeutral
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityLow, 0.3%/day
Key levels
$13.9152 week high+0.1%
$13.91Pivot R1+0.1%
$13.90Pivot+0.0%
$13.90Last close
$13.89Pivot S1−0.1%
$13.8320 day average−0.5%
$13.78Swing low (Nov 6)−0.9%
$13.7650 day average−1.0%
$13.69100 day average−1.5%
$11.81200 day average−15.0%
$5.6952 week low−59.1%
Indicators
RSI (14)
67.01
Strong, overbought above 70
Neutral
MACD
0.04
Above its signal line
Bullish
Stochastic
96.7
Near the top of its range
Overbought
ADX (14)
33.8
Trending up
Williams %R
-6.7
Oversold below −80, overbought above −20
Overbought
CCI (20)
106.8
Oversold below −100, overbought above 100
Overbought
Rate of change
+0.4%
Change over 10 sessions
Bullish
ATR (14)
$0.04
Typical daily range, 0.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchOverbought
VolatilityLow, 1.6%/day
Key levels
$13.9152 week high+0.1%
$13.91Pivot R1+0.1%
$13.90Pivot+0.0%
$13.90Last close
$13.89Pivot S1−0.1%
$13.8320 day average−0.5%
$13.78Swing low (Nov 6)−0.9%
$13.7650 day average−1.0%
$13.69100 day average−1.5%
$11.81200 day average−15.0%
$5.6952 week low−59.1%
Indicators
RSI (14)
71.90
Overbought above 70
Overbought
MACD
0.58
Below its signal line
Bearish
Stochastic
94.9
Near the top of its range
Overbought
ADX (14)
45.2
Strong uptrend
Williams %R
-3.6
Oversold below −80, overbought above −20
Overbought
CCI (20)
136.3
Oversold below −100, overbought above 100
Overbought
Rate of change
+1.9%
Change over 10 sessions
Bullish
ATR (14)
$0.23
Typical daily range, 1.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for OGN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how OGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow OGN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How OGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether OGN is in one of them and how their past OGN trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Organon &
Organon is a healthcare company based in Jersey City, New Jersey, that makes prescription medicines. Its women's health line includes contraceptive products such as an implant and a vaginal ring, along with fertility treatments. It also sells biosimilars, which are versions of biologic drugs, and established brands in areas such as cardiovascular, respiratory and dermatology care. Customers include drug wholesalers, retailers, hospitals, government agencies and managed healthcare providers, and products are sold in more than 140 countries.